Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities

被引:146
作者
Porru, Manuela [1 ]
Pompili, Luca [1 ,2 ]
Caruso, Carla [2 ]
Biroccio, Annamaria [3 ]
Leonetti, Carlo [1 ]
机构
[1] Regina Elena Inst Canc Res, UOSD SAFU, Rome, Italy
[2] Univ Tuscia, Viterbo, Italy
[3] Regina Elena Inst Canc Res, Oncogenom & Epigenet Unit, Rome, Italy
关键词
QUADRUPLEX DNA STRUCTURES; MAPK PATHWAY ACTIVATION; PHASE-III TRIAL; ANTITUMOR-ACTIVITY; PRECLINICAL MODELS; PANCREATIC-CANCER; TUMOR-SUPPRESSOR; SMALL MOLECULES; RAS; INHIBITORS;
D O I
10.1186/s13046-018-0719-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Developing drugs that target KRAS, the most frequently mutated oncogene in cancer, has not been successful despite much concerted efforts dedicated towards it in the last thirty years. Considering the key role this driver oncogene plays, the pharmacological drugging of KRAS remains a key challenge for cancer research. In this review, we highlight the emerging experimental strategies for blocking KRAS function and signaling and its direct targeting. We also report on the results in this field of research produced by our group.
引用
收藏
页数:10
相关论文
共 67 条
[1]   Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? [J].
Balasubramanian, Shankar ;
Hurley, Laurence H. ;
Neidle, Stephen .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (04) :261-275
[2]   DNA Damage Persistence as Determinant of Tumor Sensitivity to the Combination of Topo I Inhibitors and Telomere-Targeting Agents [J].
Biroccio, Annamaria ;
Porru, Manuela ;
Rizzo, Angela ;
Salvati, Erica ;
D'Angelo, Carmen ;
Orlandi, Augusto ;
Passeri, Daniela ;
Franceschin, Marco ;
Stevens, Malcolm F. G. ;
Gilson, Eric ;
Beretta, Giovanni ;
Zupi, Gabriella ;
Pisano, Claudio ;
Zunino, Franco ;
Leonetti, Carlo .
CLINICAL CANCER RESEARCH, 2011, 17 (08) :2227-2236
[3]   The role of let-7 in cell differentiation and cancer [J].
Boyerinas, Benjamin ;
Park, Sun-Mi ;
Hau, Annika ;
Murmann, Andrea E. ;
Peter, Marcus E. .
ENDOCRINE-RELATED CANCER, 2010, 17 (01) :F19-F36
[4]   Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives [J].
Brito, Hugo ;
Martins, Ana Claudia ;
Lavrado, Joao ;
Mendes, Eduarda ;
Francisco, Ana Paula ;
Santos, Sofia A. ;
Ohnmacht, Stephan A. ;
Kim, Nam-Soon ;
Rodrigues, Cecilia M. P. ;
Moreira, Rui ;
Neidle, Stephen ;
Borralho, Pedro M. ;
Paulo, Alexandra .
PLOS ONE, 2015, 10 (05)
[5]   5′-UTR RNA G-quadruplexes: translation regulation and targeting [J].
Bugaut, Anthony ;
Balasubramanian, Shankar .
NUCLEIC ACIDS RESEARCH, 2012, 40 (11) :4727-4741
[6]   Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].
Calin, GA ;
Dumitru, CD ;
Shimizu, M ;
Bichi, R ;
Zupo, S ;
Noch, E ;
Aldler, H ;
Rattan, S ;
Keating, M ;
Rai, K ;
Rassenti, L ;
Kipps, T ;
Negrini, M ;
Bullrich, F ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529
[7]   Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer [J].
Cassidy, Jim ;
Clarke, Stephen ;
Diaz-Rubio, Eduardo ;
Scheithauer, Werner ;
Figer, Arie ;
Wong, Ralph ;
Koski, Sheryl ;
Lichinitser, Mikhail ;
Yang, Tsai-Shen ;
Rivera, Fernando ;
Couture, Felix ;
Sirzen, Florin ;
Saltz, Leonard .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) :2006-2012
[8]   High-throughput sequencing of DNA G-quadruplex structures in the human genome [J].
Chambers, Vicki S. ;
Marsico, Giovanni ;
Boutell, Jonathan M. ;
Di Antonio, Marco ;
Smith, Geoffrey P. ;
Balasubramanian, Shankar .
NATURE BIOTECHNOLOGY, 2015, 33 (08) :877-+
[9]   Role of miR-143 targeting KRAS in colorectal tumorigenesis [J].
Chen, X. ;
Guo, X. ;
Zhang, H. ;
Xiang, Y. ;
Chen, J. ;
Yin, Y. ;
Cai, X. ;
Wang, K. ;
Wang, G. ;
Ba, Y. ;
Zhu, L. ;
Wang, J. ;
Yang, R. ;
Zhang, Y. ;
Ren, Z. ;
Zen, K. ;
Zhang, J. ;
Zhang, C-Y .
ONCOGENE, 2009, 28 (10) :1385-1392
[10]  
Chi Y., 2016, J EXP CLIN CANC RES, P35, DOI [10.1186/s13046-016-0320-426964533, DOI 10.1186/S13046-016-0320-426964533]